Industry Insights

  1. Why Site Relationships With Sponsors and CROs Must Evolve Now 11/24/2025

    Sites are central to drug development — we cannot run a trial without them — yet the industry continues to treat them as tactical, temporary instruments. It’s time to break this cycle, implores Jim Kremidas, executive director, Association of Multisite Research Corporations (AMRC).

  2. Open-Source Technologies Within Data Sciences Functional Outsourcing 11/21/2025

    Accelerate innovation in clinical trials by embracing open-source technologies that enhance data analysis, improve scalability, and unlock advanced predictive and machine-learning capabilities.

  3. The Evolving Role Of Healthy Participants In Early Immuno-Oncology Trials 11/21/2025

    Explore how leveraging healthy participants, advanced immune-challenge models, and high-dimensional biomarker analyses can transform early immuno-oncology development.

  4. LinkedIn Message Leads To Advocate-Pharma Pursuit Of Expanded Access 11/21/2025

    Medicus Pharma CEO Raza Bokhari, MD and Gorlin Syndrome Alliance Executive Director Meredith Weiss describe how the two a partnering to match Medicus’ noninvasive treatment for basal cell carcinoma with GSA’s patient community.

  5. Ashvattha Therapeutics Shows Real-World Focus With subQ, Bilateral Dosing For Ophthalmology Drug 11/21/2025

    Ashvattha Therapeutics shows how keeping communication open with the ophthalmic community, investigators, and KOLs can lead to a study balanced by innovation and practicality.

  6. Your Neurological Gene Therapy Trial's Secret Weapon: Caregiver Support 11/20/2025

    When it comes to neurological gene therapy trials, sponsors must prepare for participants losing the capacity to consent by enlisting the support of caregivers and legally authorized representatives.

  7. 'ONE In A MILLION' Aims To Bridge The Equity Gap In Clinical Trials 11/20/2025

    Tigerlily Foundation is launching its "ONE in a MILLION" national public-private partnership to engage one million people in high-risk communities with clinical research.

  8. How To Identify Patient-Centric Risks In The TMF With AI And Automation 11/20/2025

    Discover how AI and automation tools transform how we manage TMF content when it comes to identifying patient-centric risks.

  9. Unlock Robust And Reliable Stability Data With The Right Partner 11/19/2025

    Stability testing is essential to ensuring your drug’s stability, potency, efficacy, and safety under different controlled conditions throughout development, manufacturing, and life cycle management.

  10. How The TMF Demonstrates Patient Safety And Rights In DCTs 11/19/2025

    The TMF is not just a compliance tool, says consultant Donatella Ballerini. It's a window into how well we are protecting patients.